title: [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
abstract: According to pharmacological studies, cavinton has an effect on the end links of aminoglycosides interaction with elements of the internal ear. Basing on this property, cavinton was used as prophylaxis of neurosensory hypoacusis in 118 patients aged 17 to 63 years suffering from tuberculosis. The results of the studies have shown than cavinton not only prevents hypoacusis in patients with normal hearing but also improves it in patients with hearing problems.
authors.forename: U S
authors.initials: US
authors.lastname: Maliavina
authors.forename: Iu M
authors.initials: IuM
authors.lastname: Ovchinnikov
authors.forename: V P
authors.initials: VP
authors.lastname: Fasenko
authors.forename: B M
authors.initials: BM
authors.lastname: Maliev
authors.forename: M V
authors.initials: MV
authors.lastname: Kalinina
authors.forename: B B
authors.initials: BB
authors.lastname: Dadasheva
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014376:Tuberculosis / Q000150:complications*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine